AUG 01, 2019 11:08 AM PDT

Aspirin Usage Improves Liver Function After Embolization Treatment

WRITTEN BY: Nouran Amin

Aspirin usage has been under scrutiny in recent research. But now, studies are bringing aspirin therapy in renewed light with its association in improving liver function after an embolization procedure. In a study published in the American Journal of Roentgenology (AJR),

The therapeutic use of appropriate doses of aspirin improved the function and survival of the liver in patients who had hepatocellular carcinoma (HCC) after transarterial embolization (TAE).

Learn more about transarterial embolization (TAE):

In a retrospective review study involving 304 patients led by F. Edward Boas at Memorial Sloan Kettering Cancer Center in New York City, 42 patients were found to be taking aspirin at the time of the TAE procedure for HCC treatment. This was evident by the bilirubin levels: lower 1 day (0.9 vs 1.3, p < 0.001), 1 month (0.9 vs 1.2, p = 0.048), and 1 year (0.8 vs 1.0, p = 0.021) post-embolization.

"Although the differences in liver function test results in the groups taking and not taking aspirin were small, standard biochemical liver function tests are insensitive to early cirrhotic changes,” says Boas before clarifying further that "small changes in biochemical liver function test results might underestimate the degree of liver injury after embolization."

The usage of aspirin therapy had no indications of disparities in an initial response rate--(88% vs 90% complete response or partial response, p = 0.59), median time to progression (6.2 vs 5.2 months, p = 0.42), initial site of progression (p = 0.77)--or disparities in the fraction of patients dying with HCC progression (88% vs 89%, p = 1.00). Overall, median HCC survival after TAE procedure was measured longer for the cohorts on aspirin therapy(57 vs 23 months, p = 0.008).

Because the study was a retrospective analysis, there may be confounding variables that account for the improved survival among TAE treated HCC patients who took aspirin. Such clinical characteristics of the results, and despite the comparable liver function, more research is needed to ensure how effective and safe aspirin therapy may be in future treatments.

Source: American Roentgen Ray Society

About the Author
  • Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
APR 04, 2021
Drug Discovery & Development
Ion-Pump for Chemotherapy
APR 04, 2021
Ion-Pump for Chemotherapy
Patients of malignant brain tumors experience recurrences even after subsequent treatments. To address this issue, scien ...
MAY 14, 2021
Health & Medicine
A National Standard THC Dose for Researchers is Here
MAY 14, 2021
A National Standard THC Dose for Researchers is Here
    Whatever your stance on cannabis, almost  everyone would agree that more, better quality, research sh ...
MAY 22, 2021
Drug Discovery & Development
FDA Approves Trials for Ketamine to Treat Parkinson's
MAY 22, 2021
FDA Approves Trials for Ketamine to Treat Parkinson's
The US FDA has approved PharmaTher’s Investigational New Drug application to begin Phase 2 clinical trials for ket ...
JUN 01, 2021
Immunology
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
JUN 01, 2021
Nanoparticles Designed to Enhance Seasonal Flu Vaccines
Seasonal flu vaccines only work around 40 to 60 percent of the time, says the U.S. Centers for Disease Control and Preve ...
JUN 01, 2021
Cannabis Sciences
Can Cannabis Help Manage Symptoms of Multiple Sclerosis?
JUN 01, 2021
Can Cannabis Help Manage Symptoms of Multiple Sclerosis?
As laws around cannabinoids continue to evolve, some people with chronic illnesses such as multiple sclerosis (MS), are ...
JUN 02, 2021
Cannabis Sciences
Can CBD Help Manage Symptoms of Diabetes?
JUN 02, 2021
Can CBD Help Manage Symptoms of Diabetes?
As cannabidiol (CBD) products become increasingly mainstream, more people are using them to manage symptoms for chronic ...
Loading Comments...